Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS-FTD spectrum

被引:19
|
作者
Devenney, Emma M. [1 ,2 ]
Tu, Sicong [1 ,2 ]
Caga, Jashelle [1 ,2 ]
Ahmed, Rebekah M. [1 ,3 ]
Ramsey, Eleanor [1 ]
Zoing, Margie [1 ]
Kwok, John [1 ,4 ]
Halliday, Glenda M. [1 ,4 ]
Piguet, Olivier [1 ,3 ,4 ,5 ,6 ]
Hodges, John R. [1 ,2 ,3 ]
Kiernan, Matthew C. [1 ,2 ]
机构
[1] Univ Sydney, Brain & Mind Ctr, Sydney, NSW 2050, Australia
[2] Univ Sydney, Fac Med Hlth Translat Res Collect, Sydney, NSW, Australia
[3] Royal Prince Alfred Hosp, Inst Clin Neurosci, Sydney, NSW, Australia
[4] Univ Sydney, Fac Med & Hlth, Sch Med Sci, Sydney, NSW, Australia
[5] Univ Sydney, Fac Sci, Sch Psychol, Sydney, NSW, Australia
[6] Australian Res Council, Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia
来源
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY | 2021年 / 8卷 / 08期
基金
澳大利亚研究理事会; 澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT EXPANSION; FRONTOTEMPORAL DEMENTIA; AUDITORY HALLUCINATIONS; VISUAL HALLUCINATIONS; NETWORK CONNECTIVITY; BEHAVIORAL VARIANT; BIPOLAR DISORDER; SCHIZOPHRENIA; C9ORF72;
D O I
10.1002/acn3.51363
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The aims of this study were to (i) explore psychotic experiences across the entire amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) spectrum from a clinical and genetic perspective, (ii) determine the rate of abnormal perceptual experiences across the five sensory modalities and (iii) explore the neurobiological factors that lead to psychosis vulnerability in ALS-FTD. Methods: In a prospective case-controlled study design, 100 participants were enrolled including ALS (n = 37, 24% satisfied criteria for ALS-Plus), ALS-FTD (n = 11), bvFTD (n = 27) and healthy controls (n = 25). Psychotic experiences, perceptual abnormalities and psychosocial factors were determined by means of the clinical interview and carer and patient reports. Voxel-based morphometry analyses determined atrophy patterns in patients experiencing psychosis-like experiences and other perceptual abnormalities. Results: The rates of psychotic experiences and abnormalities of perception in each sensory modality were high across the entire ALS-FTD continuum. The rate was highest in those with C9orf72 expansions. Rates were also high in patients with pure ALS including psychosis measured by carer-based reports (18%) and self-report measures of psychotic-like experiences (21%). In an ENTER regression model, social anxiety and ACE-III scores were the best predictors of psychosis proneness, accounting for 44% of the score variance. Psychosis-like experiences and perceptual abnormalities were associated with a predominantly frontal and temporal pattern of atrophy that extended to the cerebellum and centred on the anterior thalamus. Interpretation: The model for psychosis proneness in ALS-FTD likely includes complex interactions between cognitive, social and neurobiological factors that determine vulnerability to psychosis and that may have relevance for individualised patient management.
引用
收藏
页码:1576 / 1591
页数:16
相关论文
共 19 条
  • [1] Neural circuit and synaptic dysfunctions in ALS-FTD pathology
    Mora, Santiago
    Allodi, Ilary
    FRONTIERS IN NEURAL CIRCUITS, 2023, 17
  • [2] The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics
    Vignaroli, Francesca
    Mele, Angelica
    Tondo, Giacomo
    De Giorgis, Veronica
    Manfredi, Marcello
    Comi, Cristoforo
    Mazzini, Letizia
    De Marchi, Fabiola
    PROTEOMES, 2023, 11 (01)
  • [3] CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum
    Illan-Gala, Ignacio
    Alcolea, Daniel
    Montal, Victor
    Dols-Icardo, Oriol
    Munoz, Laia
    de Luna, Noemi
    Turon-Sans, Janina
    Cortes-Vicente, Elena
    Belen Sanchez-Saudinos, Ma
    Subirana, Andrea
    Sala, Isabel
    Blesa, Rafael
    Clarimon, Jordi
    Fortea, Juan
    Rojas-Garcia, Ricard
    Lleo, Alberto
    NEUROLOGY, 2018, 91 (17) : E1619 - E1628
  • [4] Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study
    Omer, Taha
    Finegan, Eoin
    Hutchinson, Siobhan
    Doherty, Mark
    Vajda, Alice
    McLaughlin, Russell L.
    Pender, Niall
    Hardiman, Orla
    Bede, Peter
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2017, 18 (7-8) : 611 - 623
  • [5] Motor function and behaviour across the ALS-FTD spectrum
    De Silva, D.
    Hsieh, S.
    Caga, J.
    Leslie, F. V. C.
    Kiernan, M. C.
    Hodges, J. R.
    Mioshi, E.
    Burrell, J. R.
    ACTA NEUROLOGICA SCANDINAVICA, 2016, 133 (05): : 367 - 372
  • [6] Lipid Metabolic Alterations in the ALS-FTD Spectrum of Disorders
    Godoy-Corchuelo, Juan Miguel
    Fernandez-Beltran, Luis C.
    Ali, Zeinab
    Gil-Moreno, Maria J.
    Lopez-Carbonero, Juan I.
    Guerrero-Sola, Antonio
    Larrad-Sainz, Angelica
    Matias-Guiu, Jorge
    Matias-Guiu, Jordi A.
    Cunningham, Thomas J.
    Corrochano, Silvia
    BIOMEDICINES, 2022, 10 (05)
  • [7] Clinical heterogeneity within the ALS-FTD spectrum in a family with a homozygous optineurin mutation
    Parvizi, Tandis
    Klotz, Sigrid
    Keritam, Omar
    Caliskan, Haluk
    Imhof, Sophie
    Koenig, Theresa
    Haider, Lukas
    Traub-Weidinger, Tatjana
    Wagner, Matias
    Brunet, Theresa
    Brugger, Melanie
    Zimprich, Alexander
    Rath, Jakob
    Stoegmann, Elisabeth
    Gelpi, Ellen
    Cetin, Hakan
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (06): : 1579 - 1589
  • [8] Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum
    Shen, Ting
    Vogel, Jacob W.
    Duda, Jeffrey
    Phillips, Jeffrey S.
    Cook, Philip A.
    Gee, James
    Elman, Lauren
    Quinn, Colin
    Amado, Defne A.
    Baer, Michael
    Massimo, Lauren
    Grossman, Murray
    Irwin, David J.
    Mcmillan, Corey T.
    TRANSLATIONAL NEURODEGENERATION, 2023, 12 (01)
  • [9] Disease Mechanisms and Therapeutic Approaches in C9orf72 ALS-FTD
    Mayl, Keith
    Shaw, Christopher E.
    Lee, Youn-Bok
    BIOMEDICINES, 2021, 9 (06)
  • [10] A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain
    Umoh, Mfon E.
    Dammer, Eric B.
    Dai, Jingting
    Duong, Duc M.
    Lah, James J.
    Levey, Allan I.
    Gearing, Marla
    Glass, Jonathan D.
    Seyfried, Nicholas T.
    EMBO MOLECULAR MEDICINE, 2018, 10 (01) : 48 - 62